These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1012810)

  • 1. [Side effect of rubomycin on the myocardium during treatment of acute leukemia in children].
    Vorob'ev AS; Alekseev NA
    Pediatriia; 1976 Aug; (8):39-40. PubMed ID: 1012810
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in myocardial function in patients with acute leukemias under the influence of rubomycin].
    Bessmel'tsev SS; Abdulkadyrov KM
    Ter Arkh; 1994; 66(11):80-4. PubMed ID: 7900029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of cardiotoxic effect of rubidomycin under clinical conditions].
    Eichelkraut A; Orłowska-Westwood B; Polakowski P
    Pol Tyg Lek; 1981 May; 36(19):657-9. PubMed ID: 6943517
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rubomycin-induced cardiomyopathy in rats and the potential for therapy with a peptide preparation from the heart].
    Andreeva LI; Khavinson VKh
    Biull Eksp Biol Med; 1993 Sep; 116(9):233-5. PubMed ID: 8117986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative analysis of the changes in myocardial electrical and contractile activity in rats exposed to rubomycin and its nitroxyl derivative].
    Vasilets LA; Guseva TI; Mokh VP
    Farmakol Toksikol; 1985; 48(6):33-7. PubMed ID: 4085626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiotoxic effect of anthracycline antibiotics].
    Jovanović I; Ceranić LJ; Simeunović S; Cvetković P
    Bilt Hematol Transfuz; 1983; 11(2-3):51-7. PubMed ID: 6680300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the blood coagulation system in patients with acute leukemia during treatment with rubomycin].
    Zhukovskaia ES; Khvatova NV
    Probl Gematol Pereliv Krovi; 1975 Oct; 20(10):35-9. PubMed ID: 1060058
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
    Haruyama H; Shimazaki C; Nakanishi S; Hamami T; Nisio A; Isemura T; Katsume H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polycardiographic evaluation of cardiotoxic effects of rubidomycin in patients with acute leukemia].
    Wodniecki J; Prochaczek F; Holowiecki J; Stella B
    Acta Haematol Pol; 1976; 7(3):195-8. PubMed ID: 983667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy].
    Svojgrová M; Slechtová J; Hůla J
    Vnitr Lek; 1991 Feb; 37(2):151-9. PubMed ID: 2021075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiac toxicity of rubidomycin. Apropos of 2 cases].
    Laine JL; Julienne O; Leroy J; Lamagnère JP; Laugier J; Desbuquois G
    Pediatrie; 1973 Mar; 28(2):201-10. PubMed ID: 4725976
    [No Abstract]   [Full Text] [Related]  

  • 12. Daunorubicin-prednisone in the treatment of acute nonlymphocytic leukemia.
    Peterson BA; Bloomfield CD; Theologides A; Kennedy BJ
    Cancer Treat Rep; 1981; 65 Suppl 4():29-33. PubMed ID: 6955011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Toxic side effects of daunomycin in children].
    Massimo L
    Blut; 1970 Jan; 20(1):44-56. PubMed ID: 5414705
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis and treatment of rubomycin-induced heart lesions in children with leukemia].
    Alekseev NA; Zil'berman MV
    Gematol Transfuziol; 1989 Sep; 34(9):37-40. PubMed ID: 2684736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
    Cassileth PA; Katz ME
    Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ultrastructural manifestations of impairment of contractile protein synthesis in rat cardiomyocytes after administration of rubomycin].
    Semenov DE; Nepomniashchikh LM; Tumanov VP
    Biull Eksp Biol Med; 1982 Sep; 94(9):102-5. PubMed ID: 7171807
    [No Abstract]   [Full Text] [Related]  

  • 17. Interhospital differences in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
    Scand J Haematol; 1979 Aug; 23(2):119-23. PubMed ID: 386480
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial: Adriamycin and the heart.
    Lancet; 1974 Jun; 1(7870):1325. PubMed ID: 4134302
    [No Abstract]   [Full Text] [Related]  

  • 19. [Early daunorubicin cardiotoxicity and fatal outcome in a child with acute myeloblastic leukemia (M2)].
    Rizzari C; Santamaria M; Galli MA; Jankovic M; Uderzo C
    Pediatr Med Chir; 1987; 9(6):749-50. PubMed ID: 3481847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I clinical trial of orally administered 4-demethoxydaunorubicin (idarubicin) with pharmacokinetic and in vitro drug sensitivity testing in children with refractory leukemia.
    Pui CH; de Graaf SS; Dow LW; Rodman JH; Evans WE; Alpert BS; Murphy SB
    Cancer Res; 1988 Sep; 48(18):5348-52. PubMed ID: 3165708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.